Nuclear medicine is a specialty dealing with diagnosis and treatment using labeled radionuclides compounds (radiopharmaceuticals), placed in the human body. Nuclear medicine diagnostic imaging methods are used for visualization, characterization and measurement of biological processes at molecular and cellular level; having these we can provide an early diagnosis since metabolic changes precede anatomical ones and can be found much before structural changes occur in the body. With the help of high-tech hybrid equipment of latest generation – SPECT/CT and PET/CT – it is possible to obtain a unique composite image, combining structural and functional changes – for the accurate diagnosis and determining the most adequate patient therapy.
Nuclear medicine diagnostics finds its application in visualization and monitoring of a number of benign diseases affecting the cardiovascular system, endocrine system, joints, lungs, kidney function, etc., and gives an objective assessment of the therapeutic effect as well as early detection of recurrence and metastases.
